Benzinga's options scanner just detected over 13 options trades for GSK GSK summing a total amount of $374,725.
At the same time, our algo caught 3 for a total amount of 129,320.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $34.0 to $38.0 for GSK over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for GSK's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of GSK's whale activity within a strike price range from $34.0 to $38.0 in the last 30 days.
GSK Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| GSK | PUT | TRADE | BEARISH | 05/19/23 | $38.00 | $48.1K | 221 | 0 |
| GSK | CALL | SWEEP | BULLISH | 04/21/23 | $38.00 | $45.3K | 93 | 3.0K |
| GSK | PUT | TRADE | BULLISH | 08/18/23 | $37.00 | $44.2K | 232 | 0 |
| GSK | CALL | TRADE | BULLISH | 04/21/23 | $34.00 | $39.0K | 377 | 0 |
| GSK | CALL | SWEEP | BULLISH | 06/16/23 | $36.00 | $38.3K | 3.6K | 1.7K |
Where Is GSK Standing Right Now?
- With a volume of 1,538,262, the price of GSK is up 1.7% at $35.49.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 34 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for GSK, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
